The level of tumor killing by bismuth nanoparticles (BiNPs) as radiosensitizers depends
strongly on the powerful particle–matter interaction. However, this same radiation leads to …

Achieving a complete response to cancer treatment is a severe challenge, and has puzzled
humans for a long time. Fortunately, radiotherapy (RT) gives rise to a common clinical …

Despite the development of nanomaterials with high-Z elements for radiosensitizers, most of
them suffer from their oxygen-dependent behavior in hypoxic tumor, nonideal selectivity to …

In high-Z element enhanced radiotherapy strategies, the clinical potential of metal-based
nanocomposites is always reduced by the serious side effects of leaked heavy metal ions. In …

Radiotherapy (RT), as one of the main methods of clinical tumor treatment, has been applied
to the treatment of most solid tumors. However, the effect of RT is compromised by the …

Tumor hypoxia is known to be one of the vital factors that aggravate tumor resistance to
radiation therapy (RT) in which oxygen plays a critical role in tumor destruction. Herein, we …

Bismuth-containing nanoparticles (BNPs) are potential enhancers for tumor radiotherapy.
Improving the bioavailability and developing synergistic therapeutic regimens benefit the …

Low-dose radioresistance continues to be one of the major limitations for clinical curative
treatment of cancer. Luckily, nanotechnology mediated by multifunctional nanomaterials …

Combination therapy such as radiotherapy combined with chemotherapy has attracted
excessive interest in the new cancer research area. Therefore, developing nanobiomaterials …

An unmet need in nanomedicine is to prepare biocompatible and renal clearable
nanoparticles by controlling the diameter, composition and surface properties of the …